These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37144752)
41. Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice. Park J; Shin E; Yeom JH; Choi Y; Joo M; Lee M; Kim JH; Bae J; Lee K J Microbiol; 2022 Jan; 60(1):128-136. PubMed ID: 34964948 [TBL] [Abstract][Full Text] [Related]
42. Peptidomics-based identification of an antimicrobial peptide derived from goat milk fermented by Lactobacillus rhamnosus (C25). Iram D; Kindarle UA; Sansi MS; Meena S; Puniya AK; Vij S J Food Biochem; 2022 Dec; 46(12):e14450. PubMed ID: 36226982 [TBL] [Abstract][Full Text] [Related]
43. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742 [TBL] [Abstract][Full Text] [Related]
44. Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens. Jiang Z; Mant CT; Vasil M; Hodges RS Chem Biol Drug Des; 2018 Jan; 91(1):75-92. PubMed ID: 28636788 [TBL] [Abstract][Full Text] [Related]
45. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii. Tiwari V; Tiwari D; Patel V; Tiwari M Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748 [TBL] [Abstract][Full Text] [Related]
46. Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii. Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK Microb Pathog; 2020 Oct; 147():104205. PubMed ID: 32353580 [TBL] [Abstract][Full Text] [Related]
47. Probing intermolecular interactions and binding stability of antimicrobial peptides with beta-lactamase of Chakkyarath V; Natarajan J J Biomol Struct Dyn; 2022; 40(24):13641-13657. PubMed ID: 34676806 [TBL] [Abstract][Full Text] [Related]
48. From In Vitro Promise to In Vivo Reality: An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides. Carrera-Aubesart A; Li J; Contreras E; Bello-Madruga R; Torrent M; Andreu D Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337261 [TBL] [Abstract][Full Text] [Related]
49. Wide-open conformation of UDP-MurNc-tripeptide ligase revealed by the substrate-free structure of MurE from Acinetobacter baumannii. Jung KH; Kim YG; Kim CM; Ha HJ; Lee CS; Lee JH; Park HH FEBS Lett; 2021 Jan; 595(2):275-283. PubMed ID: 33230844 [TBL] [Abstract][Full Text] [Related]
50. Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Peng J; Wang Y; Wu Z; Mao C; Li L; Cao H; Qiu Z; Guo G; Liang G; Shen F Drug Des Devel Ther; 2023; 17():977-992. PubMed ID: 37020803 [TBL] [Abstract][Full Text] [Related]
51. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078 [TBL] [Abstract][Full Text] [Related]
52. C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Stewart NK; Toth M; Alqurafi MA; Chai W; Nguyen TQ; Quan P; Lee M; Buynak JD; Smith CA; Vakulenko SB mBio; 2022 Jun; 13(3):e0036722. PubMed ID: 35420470 [TBL] [Abstract][Full Text] [Related]
53. Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics. Gallagher P; Baker S J Infect; 2020 Dec; 81(6):857-861. PubMed ID: 33115656 [TBL] [Abstract][Full Text] [Related]
54. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2. Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355 [TBL] [Abstract][Full Text] [Related]
55. In vitro synergistic action of TAT-RasGAP Vizzarro G; Jacquier N J Glob Antimicrob Resist; 2022 Dec; 31():295-303. PubMed ID: 36270448 [TBL] [Abstract][Full Text] [Related]
56. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays. Skariyachan S; Manjunath M; Bachappanavar N J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934 [TBL] [Abstract][Full Text] [Related]
57. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance? Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762 [TBL] [Abstract][Full Text] [Related]
58. Molecular Docking, Anti-Biofilm & Antibacterial Activities and Therapeutic Index of mCM11 Peptide on Acinetobacter baumannii Strains. Eshtiaghi S; Nazari R; Fasihi-Ramandi M Curr Microbiol; 2023 Apr; 80(6):191. PubMed ID: 37093361 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant das Neves RC; Mortari MR; Schwartz EF; Kipnis A; Junqueira-Kipnis AP Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30974767 [TBL] [Abstract][Full Text] [Related]
60. Antimicrobial activity of D-amino acid in combination with photo-sonoactivated hypericin nanoparticles against Acinetobacter baumannii. Pourhajibagher M; Hosseini N; Bahador A BMC Microbiol; 2023 Jan; 23(1):23. PubMed ID: 36658487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]